| Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open … J Guinney, T Wang, TD Laajala, KK Winner, JC Bare, EC Neto, SA Khan, ... The Lancet Oncology 18 (1), 132-142, 2017 | 161 | 2017 |
| Qigong intervention for breast cancer survivors with complaints of decreased cognitive function JS Myers, M Mitchell, S Krigel, A Steinhoff, A Boyce-White, ... Supportive Care in Cancer 27, 1395-1403, 2019 | 71 | 2019 |
| Lysobacter xinjiangensis sp. nov., a moderately thermotolerant and alkalitolerant bacterium isolated from a gamma-irradiated sand soil sample M Liu, Y Liu, Y Wang, X Luo, J Dai, C Fang International journal of systematic and evolutionary microbiology 61 (2 …, 2011 | 38 | 2011 |
| Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes MA Earp, R Raghavan, Q Li, J Dai, SJ Winham, JM Cunningham, ... Oncotarget 8 (29), 46891, 2017 | 28 | 2017 |
| Transcriptomic characterization of endometrioid, clear cell, and high-grade serous epithelial ovarian carcinoma BL Fridley, J Dai, R Raghavan, Q Li, SJ Winham, X Hou, SJ Weroha, ... Cancer epidemiology, biomarkers & prevention 27 (9), 1101-1109, 2018 | 26 | 2018 |
| Genome-wide study of response to platinum, Taxane, and combination therapy in ovarian cancer: In vitro phenotypes, inherited variation, and disease recurrence BL Fridley, TM Ghosh, A Wang, R Raghavan, J Dai, EL Goode, JK Lamba Frontiers in genetics 7, 37, 2016 | 26 | 2016 |
| Treatment outcomes for rheumatoid arthritis associated interstitial lung disease; a real-world, multisite study of the impact of immunosuppression on pulmonary function trajectory SM Matson, M Baqir, T Moua, M Marll, J Kent, NS Iannazzo, RD Boente, ... Chest, 2022 | 15 | 2022 |
| Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results A Saeed, R Park, J Dai, R Al-Rajabi, A Kasi, J Baranda, S Williamson, ... Cell Reports Medicine, 2023 | 14 | 2023 |
| Pupillary response: cognitive effort for breast cancer survivors JS Myers, M Kahya, M Mitchell, J Dai, J He, S Moon, K Hamilton, M Valla, ... Supportive Care in Cancer 27 (3), 1121-1128, 2019 | 8 | 2019 |
| Platelet-Dependent Inflammatory Dysregulation in Patients with stages 4-5 Chronic Kidney Disease-A Mechanistic Clinical Study A Corken, J Ware, J Dai, JM Arthur, S Smyth, CL Davis, J Liu, TO Harville, ... Kidney360, 2022 | 7 | 2022 |
| Trends for and Clinical Factors Associated with Choice of Oral P2Y12 Inhibitors for Patients on Chronic Dialysis N Jain, SL Hunt, H Cui, MA Phadnis, JD Mahnken, TI Shireman, J Dai, ... Cardiovascular drugs and therapy 33 (5), 511-521, 2019 | 6 | 2019 |
| A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma. W Sun, N Veeramachaneni, R Al-Rajabi, R Madan, A Kasi, ... Cancer Medicine, 2023 | 5 | 2023 |
| Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis N Jain, MA Phadnis, SL Hunt, J Dai, TI Shireman, CL Davis, JL Mehta, ... Kidney International Reports 6 (9), 2381-2391, 2021 | 5 | 2021 |
| An ensemble-based Cox proportional hazards regression framework for predicting survival in metastatic castration-resistant prostate cancer (mCRPC) patients R Meier, S Graw, J Usset, R Raghavan, J Dai, P Chalise, S Ellis, B Fridley, ... F1000Research 5, 2016 | 5 | 2016 |
| Pilot Feasibility Study Examining Pupillary Response During Driving Simulation as a Measure of Cognitive Load in Breast Cancer Survivors JS Myers, N Alissa, M Mitchell, J Dai, J He, S Moon, A O’Dea, J Klemp, ... Oncology nursing forum 47 (2), 203, 2020 | 4 | 2020 |
| Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease N Jain, A Corken, JM Arthur, J Ware, N Arulprakash, J Dai, MA Phadnis, ... Vascular Pharmacology, 107143, 2023 | 3 | 2023 |
| Impact of Fellowship-Trained Andrology and Sexual Medicine Specialists on Performance on the Annual American Urological Association In-Service Examination AM El-Arabi, SM Alam, J Dai, J Thompson, M Baden, J Siculietano, ... Urology 157, 51-56, 2021 | 2 | 2021 |
| Age Modifies Intracranial and Gastrointestinal Bleeding Risk from P2Y12 Inhibitors in Patients Receiving Dialysis N Jain, BC Martin, J Dai, MA Phadnis, L Al-Hindi, TI Shireman, ... Kidney360, 2022 | 1 | 2022 |
| Accurate Medication Adherence Measurement Using Administrative Data for Frequently Hospitalized Patients RS Rasu, SL Hunt, J Dai, H Cui, MA Phadnis, N Jain Hospital Pharmacy, 0018578720918550, 2020 | 1 | 2020 |
| Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort A Saeed, R Park, H Pathak, AN Al-Bzour, J Dai, M Phadnis, R Al-Rajabi, ... Nature Communications 15 (1), 1533, 2024 | | 2024 |
